Numan
ID: 610602
Seedtable Score
46
Startups
2
Funding Rounds
2
Investors
$52.97m
Money raised
Overview
Numan, based in London, addresses the widespread health issue of erectile dysfunction (ED) with a direct-to-consumer model. Offering a personalized approach, it stands out compared to traditional doctor visits or over-the-counter medications. By focusing on ED, Numan aims to alleviate personal distress, relationship issues, and potential health complications. Supported by investors like Anthemis and VNV Global, the startup is well-positioned to tap into a niche market with high demand and limited specialized options.
- Website: https://numan.com
- Business model: b2c
- Company size: 11 - 51 employees
- Headquarters: London, UK
- Founded: 2018
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Funding
Funding series
Funding Series Analysis
The company Numan has raised a total of $52.97m in funding over 2 rounds.
Key Insights:
- Series B: $40m
- Series A: $12.97m
Numan Series A (2020, $12M)
$12.97m
Numan Series B (2021, $40M)
$40m